2019 Novel Coronavirus (2019-nCoV), Wuhan, China: Interim healthcare infection prevention and control recommendations for patients under investigation for 2019 novel coronavirus

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  This interim guidance is for staff at local and state health departments, infection prevention and control professionals, healthcare providers, and healthcare workers who are coordinating the home care and isolation1 of people who are confirmed to have, or being evaluated for 2019 novel coronavirus (2019-nCoV) infection (see Criteria to Guide Evaluation of Patients Under Investigation (PUI) for 2019-nCoV). This document does not apply to patients in healthcare settings. For interim healthcare infection prevention and control recommendations, (see Interim Healthcare Infection Prevention and Control Recommendations). CDC will update this interim guidance as needed and as more information becomes available.
• Subjects:
  Communicable Disease Control Communicable Diseases, Emerging Coronavirus Infections/prevention & Control COVID-19 Pneumonia Respiratory Tract Infections
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Genre:
  Guideline
• Place as Subject:
  China
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:25ede79885760d2fbdc63c7d671b90c1f711395d0f5275d9e8b093131bce81ae8bc4084e505cacfd3db6a0cd255b0c5ff3acb25f8283a3511b13d8e7f6e0d097
• Download URL:
  https://stacks.cdc.gov/view/cdc/84448/cdc_84448_DS1.pdf
• File Type:
  [PDF - 44.84 KB ]